Skip to main content
UniHealth

Doctor search

Andrew Lin Ji, MD

Dermatology · New York

NPI 1265843460

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Office
1

Offices

1 location · Icahn School of Medicine at Mount Sinai · 2,809 clinicians in this group

Looking this up.

Hospitals listed: Mount Sinai Hospital. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Ji’s office at (212) 241-8234 to ask if they take your plan before you enroll.

California Medical Board record

Licence A137943 · Delinquent

Licence status: Delinquent · since 2015 · expires 2023-01-31 · Cornell University Medical College.

License renewal fee has not been paid. No practice is permitted.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Mount Sinai HospitalNew York, NYAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Mount Sinai Health System, which runs 5 hospitalsHome of Tisch Cancer Institute, a National Cancer Institute designated cancer centrePatients rate it 3 of 5 · 69% would definitely recommend it
    Overall rating: 4 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.9 (11 to 15) · 878 cases, Jan 2024 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.473, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.513, Oct 2024 – Sep 2025Better than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 3.9 (3 to 5.1) · 878 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Mount Sinai Hospital

Behind the star rating — Deaths: 4 better, 4 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 1 worse of 8 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Mount Sinai Hospital
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits12.9 (11 to 15) · 878 casesWorseJan 2024 – Dec 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.473BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.513BetterOct 2024 – Sep 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits3.9 (3 to 5.1) · 878 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.56 (0.9 to 2.21) · 4,503 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.03 (0.88 to 1.18)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths172.14 (136.78 to 207.5) · 260 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.4 · 155 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.6 · 168 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.1 · 139 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.9 · 785 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths12.4 · 774 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.8 · 589 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.2 · 10,714 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.08 (0 to 0.24) · 19,045 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.36 (0.21 to 0.52) · 20,760 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths4.47 (3.23 to 5.72) · 7,869 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.36 (0.41 to 2.3) · 3,840 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.62 (0.77 to 2.47) · 7,428 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths7.64 (5.02 to 10.27) · 3,845 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths4.23 (2.36 to 6.09) · 4,008 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.19 (0 to 2.45) · 1,428 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.93 (0.63 to 1.23) · 15,577 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths2.7 · 621 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.718No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.654No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections1.779No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.813No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits15.2 · 385 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.9 · 1,625 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits1.7 · 236 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits21.5 · 883 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits37.6 · 760 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits19.6 · 1,228 casesNoneJul 2023 – Jun 2025
Rate of readmission after hip/knee replacementUnplanned return visits4.2 · 669 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.5 · 184 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20.2 · 371 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.3 (9.3 to 16.1) · 681 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.7 to 1.1) · 1,157 casesNo differentJan 2024 – Dec 2024

What patients said (799 patients answered, 16% of those asked)

Patient survey stars by topic at Mount Sinai Hospital
Cleanliness3
Nurse communication3
Doctor communication3
Communication about medicines2
Discharge information3
Overall hospital rating3
Quietness2
Recommend hospital3
Share of patients giving the best answer at Mount Sinai Hospital
Room was "always" clean66%
Nurses "always" communicated well76%
Doctors "always" communicated well80%
Staff "always" explained60%
Yes, staff "did" give patients this information85%
Yes, staff "did" give patients information about help after discharge81%
Doctors "always" explained things so they could understand75%
Doctors "always" listened carefully79%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)69%
Staff "always" explained new medications75%
Nurses "always" explained things so they could understand72%
Nurses "always" listened carefully72%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night44%
"YES", patients would definitely recommend the hospital69%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$4,141

Medicare paid this office $4,141 for 45 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Return visit (30+ min)22$2,113$78
Short return visit (20+ min)11$517$47

Procedures Medicare counted

Procedure volume Medicare published
Removal of skin lesions1-10None
Skin biopsy1-10None

Who their Medicare patients are

45 Original Medicare patients in 2024. Average age 68 · Under 65 27% · Women 69% · Also on Medicaid 76% · Health risk score 1.79. Sicker patients than 9 in 10 peers; the typical dermatology clinician is at 1.01.

Conditions among them: High blood pressure 67% · Diabetes 33%.

The office billed $19,117, Medicare allowed $5,700 and paid $4,141; for 65 services of 12 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20244565681.79$19,117$4,141
20232239712.14$10,010$1,826
202283253731.66$72,484$19,905
202124117761.92$16,519$3,046
202057171731.52$28,923$5,505
201953274731.19$20,312$6,169
20181643741.76$5,050$1,498

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2022: 6 services

Original Medicare services billed in 2022
Therapy procedure using ultraviolet radiation with tar or petroleum jelly application22$8,772$110
Return visit (30+ min)17$2,881$115
New patient visit (45+ min)13$1,887$145
Destruction of precancer skin growth, 1 growth15$949$45
Short return visit (20+ min)13$941$67
Destruction of precancer skin growth, 2-14 growths12$306$7

2020: 2 services

Original Medicare services billed in 2020
Short return visit (20+ min)26$1,078$37
Short return visit (20+ min)19$906$41

2019: 5 services

Original Medicare services billed in 2019
Short return visit (20+ min)37$2,105$42
Destruction of precancer skin growth, 1 growth21$1,023$38
Destruction of skin growth, 1-14 growths13$940$63
New patient visit (30+ min)15$878$59
Destruction of precancer skin growth, 2-14 growths17$237$2

Medicaid work

$1,354 in 2022

Medicaid paid $1,354 for 15 billed services this clinician did in 2022, up to 15 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2022
Return visit (30+ min)15$1,354
Medicaid work by year
202215115$1,354
2021559259$36,802
2020563347$33,804
2019499243$26,755
See the largest Medicaid services in earlier years

2021

Largest Medicaid services in 2021
Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 5-10 minutes364$28,580
OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES195$8,222

2020

Largest Medicaid services in 2020
Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 5-10 minutes267$22,695
OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES283$10,004
Online evaluation and management service provided by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient or guardian, not originating from a related E/M service provided within the previous 7 days, using the Internet or similar electronic communications network13$1,105

2019

Largest Medicaid services in 2019
Online evaluation and management service provided by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient or guardian, not originating from a related E/M service provided within the previous 7 days, using the Internet or similar electronic communications network283$21,909
OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES216$4,846

Drugs they prescribed that Part D paid

$60,183

Pharmacies billed $60,183 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 113) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.

93 generic and 20 brand-name prescriptions · $60,183 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Ketoconazole13$279$21
Triamcinolone Acetonide16$251$16

Year by year

Part D prescribing by year
2024113380% (0)18%$60,183
2023129330% (0)18%$171,763
2022141490% (0)11%$7,313
2021115380% (0)12%$8,107
2020166480% (0)11%$6,436
201979330% (0)None$4,900
201827130% (0)None$1,850
20152914NoneNone$1,050
201430NoneNoneNone$1,164

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 3 drugs

Part D drugs prescribed in 2023
Clobetasol Propionate16$2,150$134
Ketoconazole18$633$35
Triamcinolone Acetonide19$245$13

2022: 3 drugs

Part D drugs prescribed in 2022
Clobetasol Propionate16$1,108$69
Fluocinonide17$1,028$60
Triamcinolone Acetonide31$339$11

2021: 4 drugs

Part D drugs prescribed in 2021
Fluocinonide35$2,726$78
Clobetasol Propionate12$1,605$134
Betamethasone Dipropionate11$1,471$134
Triamcinolone Acetonide18$200$11

2020: 6 drugs

Part D drugs prescribed in 2020
Clindamycin Phosphate13$1,161$89
Fluocinonide23$1,055$46
Doxycycline Hyclate12$746$62
Triamcinolone Acetonide38$636$17
Mupirocin16$95$6
Hydrocortisone12$40$3

2019: 2 drugs

Part D drugs prescribed in 2019
Triamcinolone Acetonide21$369$18
Hydrocortisone13$66$5

Money from drug and device companies

$27 in 2025

Industry payments by year
202511None$27
202344None$125,173
202235None$125,070
202011None$25
201911None$15

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Galderma Laboratories L.P.Nemluvio$27
1 payment
  • Meals for Nemluvio · 2025-02-18 · $27
See the published payment
Every published payment
Galderma Laboratories L.P.Meals · 2025-02-18Nemluvio$27
See earlier years (2023, 2022, 2020, 2019)

2023: $125,173

Payments by company in 2023
Regeneron PharmaceuticalsNone$125,000
1 payment
  • Grant · 2023-11-27 · $125,000
Boehringer Ingelheim PharmaceuticalsNone$142
1 payment
  • Meals · 2023-03-16 · $142
Regeneron Healthcare SolutionsDupixent$16
1 payment
  • Meals for Dupixent · 2023-03-01 · $16
PfizerNone$15
1 payment
  • Meals · 2023-05-11 · $15

2022: $125,070

Payments by company in 2022
Regeneron PharmaceuticalsNone$125,000
1 payment
  • Grant · 2022-11-14 · $125,000
AbbvieSkyrizi$58
3 payments
  • Meals for Skyrizi · 2022-07-06 · $24
  • Meals for Skyrizi · 2022-05-25 · $17
  • Meals for Skyrizi · 2022-05-04 · $16
LEO PharmaAdbry$12
1 payment
  • Meals for Adbry · 2022-06-01 · $12

2020: $25

Payments by company in 2020
AbbVieSkyrizi$25
1 payment
  • Meals for Skyrizi · 2020-08-12 · $25

2019: $15

Payments by company in 2019
AbbVieHumira$15
1 payment
  • Meals for Humira · 2019-01-30 · $15

Professional record

NPI
1265843460
Licence
CA A137943, NY 310434California A137943: Delinquent · expires 2023-01-31
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207N00000X (207N00000X); Student in a training program (390200000X)
Mailing address
5 E 98th St, New York, NY, 10029
NPI first listed
2014-05-11
NPI last updated
2021-09-03
NPI record certified
2021-09-03

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 420 E 70th St Apt 15g, New York, NY, 10021 · 300 Pasteur Dr, Stanford, CA, 94305